Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

Dostarlimab is under clinical development by GSK and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction.

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III drugs for Gastric Cancer have a 46% phase transition ...

The FDA has approved tislelizumab plus chemotherapy for the treatment of patients with newly diagnosed, locally advanced or ...

San Mateo, California Monday, December 30, 2024, 18:00 Hrs [IST] ...

More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.

BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain ...

These include peptic ulcers, acute and atrophic gastritis, intestinal metaplasia, gastric adenocarcinoma and gastric B-cell lymphoma. Various bacterial virulence factors are associated with the ...

INR:2435. charminar satta chart 2022 Review of clinical developments of China's Class 1 new drugs in February 2020 Tumor Therapeutic Fields + Chemother ...

INR:0934. jai vs up kabaddi US$570 million! Leo obtains exclusive global license for new dermatitis and asthma drugs from companies on both sides of the Taiwan ...